Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur M Friedlander

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Virology|May 12, 2025
Early short-course treatment fails to prevent disease or relapse upon discontinuance of treatment in infections in addition to COVID-19Arthur M Friedlander
The New England Journal of Medicine|June 4, 2015
Management of potential bioterrorism-related conditionsArthur M Friedlander
JAMA|July 2, 2002
Diagnosis and treatment of cutaneous anthraxArthur M Friedlander
Vaccine|October 20, 2009
Advances in the development of next-generation anthrax vaccinesArthur M Friedlander, Stephen F Little
Human Vaccines & Immunotherapeutics|August 3, 2012
Military vaccines in today's environmentConnie S Schmaljohn, Leonard A Smith, Arthur M Friedlander
Journal of Visualized Experiments : Jove|June 9, 2020
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated PathogensJennifer Chua, Donald J Chabot, Tammy Putmon-Taylor, et al.
Biochemistry|October 22, 2014
A reaction path study of the catalysis and inhibition of the Bacillus anthracis CapD γ-glutamyl transpeptidaseIlja V Khavrutskii, Patricia M Legler, Arthur M Friedlander, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Treatment of experimental anthrax with recombinant capsule depolymeraseAngelo Scorpio, Steven A Tobery, Wilson J Ribot, et al.
FEMS Microbiology Letters|June 13, 2017
Green tea and epigallocatechin-3-gallate are bactericidal against Bacillus anthracisShane D Falcinelli, Maggie C Shi, Arthur M Friedlander, et al.
Microbial Pathogenesis|September 8, 2004
The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulenceItai Mendelson, Steve Tobery, Angelo Scorpio, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Virology|May 12, 2025
Early short-course treatment fails to prevent disease or relapse upon discontinuance of treatment in infections in addition to COVID-19Arthur M Friedlander
The New England Journal of Medicine|June 4, 2015
Management of potential bioterrorism-related conditionsArthur M Friedlander
JAMA|July 2, 2002
Diagnosis and treatment of cutaneous anthraxArthur M Friedlander
Vaccine|October 20, 2009
Advances in the development of next-generation anthrax vaccinesArthur M Friedlander, Stephen F Little
Human Vaccines & Immunotherapeutics|August 3, 2012
Military vaccines in today's environmentConnie S Schmaljohn, Leonard A Smith, Arthur M Friedlander
Journal of Visualized Experiments : Jove|June 9, 2020
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated PathogensJennifer Chua, Donald J Chabot, Tammy Putmon-Taylor, et al.
Biochemistry|October 22, 2014
A reaction path study of the catalysis and inhibition of the Bacillus anthracis CapD γ-glutamyl transpeptidaseIlja V Khavrutskii, Patricia M Legler, Arthur M Friedlander, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Treatment of experimental anthrax with recombinant capsule depolymeraseAngelo Scorpio, Steven A Tobery, Wilson J Ribot, et al.
FEMS Microbiology Letters|June 13, 2017
Green tea and epigallocatechin-3-gallate are bactericidal against Bacillus anthracisShane D Falcinelli, Maggie C Shi, Arthur M Friedlander, et al.
Microbial Pathogenesis|September 8, 2004
The NheA component of the non-hemolytic enterotoxin of Bacillus cereus is produced by Bacillus anthracis but is not required for virulenceItai Mendelson, Steve Tobery, Angelo Scorpio, et al.
Pageof 6